This commentary or analysis examines the gap in outbreak response preparedness beyond vaccines, focusing on the underdevelopment of diagnostics and therapeutics for epidemic and pandemic-prone pathogens.
The paper argues that diagnostics and therapeutics remain critically underfunded and underdeveloped relative to vaccines in outbreak response frameworks, leaving a dangerous gap in global health security.
As a commentary or perspective piece, this paper does not present primary clinical trial data or patient-level outcomes, limiting direct evidence-based conclusions.
Clinicians and health systems should advocate for greater investment in point-of-care diagnostics and pathogen-specific therapeutics alongside vaccine development for outbreak preparedness. Relying on vaccines alone leaves patients vulnerable during the critical early phase of an outbreak.
Explore related topics
